Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Tongchuang Biotechnology is a China-based biotechnology company primarily focused on providing research and development services and developing its own pipeline of therapeutic candidates. The company operates as a Contract Research Organization (CRO) specializing in molecular biology, protein expression, and antibody development services to support the broader life sciences industry. In addition to its service offerings, Hangzhou Tongchuang engages in the discovery of novel biologics and small molecules targeting infectious diseases and oncology. The company leverages its technical expertise in genetic engineering and protein purification to accelerate drug discovery processes for its partners and internal programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Tongchuang Biotechnology.